Skip to main content
. 2020 Nov 19;11(11):1367. doi: 10.3390/genes11111367

Figure 1.

Figure 1

Overall survival (OS) probability (A) was assessed according to pathologic complete response (B) and therapeutic regime (C). The effect of deficiency in DNA repair and surveillance genes was evaluated for overall survival (D) and disease-free survival (E). PCR: Pathologic complete response; CCT: Conventional chemotherapy; Ch-PLA: Chemotherapy plus platinum salts.